Cytek Biosciences Inc CTKB
๐ Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-07-23 |
| Shares Out. | 129,140,000 |
| Website | cytekbio.com โ |
| Phone | 18004831140 |
| Employees | 702 |
| Revenue | $48.1M |
| Gross Profit | $28.3M |
| Net Income | -$12.2M |
| Free Cash Flow | -$12.1M |
| Total Assets | $446.9M |
| Total Liabilities | $125.0M |
| Equity | $322.0M |
About Cytek Biosciences Inc
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
Cytek Biosciences Inc is a publicly traded company under the ticker symbol CTKB on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
๐ Analyst Ratings
10 analysts (2026-09-01)

